, Tracking Stock Market Picks
Enter Symbol:
Oragenics, Inc. (OGEN) [hlAlert]

up 1.73 %

Oragenics, Inc. (OGEN) rated Buy with price target $5 by Griffin Securities

Posted on: Tuesday,  Nov 27, 2012  12:25 PM ET by Griffin Securities

Griffin Securities rated Buy Oragenics, Inc. (AMEX: OGEN) on 11/27/2012, when the stock price was $2.30. Since
then, Oragenics, Inc. has gained 1.74% as of 08/27/2015's recent price of $2.34.
If you would have followed this Griffin Securities's recommendation on OGEN, you would have gained 1.73% of your investment in 1003 days.

Oragenics Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of a variety of products and technologies. The Company has a number of technologies, products and platforms. Its Consumer Healthcare group has two product categories: Oral Probiotics that contain its ProBiora3 (Probiotics) technology (food additive) and products for weight loss that revolve around its LPT3-04 weight loss agent (food/nutritional supplement). The Company?s Antibiotics group includes Differentially Protected Orthogonal Lantionine Technology (DPOLT) lantibiotic synthesis platform (for generation of drug products) and MU 1140, mutacin (drug). Its Diagnostics division has two platforms for the identification of genetic targets that can be used in diagnostic tests, as well as in vaccines and therapeutics. The two platforms are Proteomic-based In-Vivo Induced Antigen Technology (PIVIAT) and Proteomic-based Change Mediated Antigen Technology (PCMAT).

Griffin Securities
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/27/2012 12:25 PM Buy
2.30 5.00
as of 12/31/2012
1 Week up  17.85 %
1 Month up  27.53 %
3 Months up  14.78 %
1 YTD up  14.78 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy